103 related articles for article (PubMed ID: 36379109)
1. Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods.
Perri M; Guta A; Kaminski N; Bonn M; Kolla G; Bayoumi A; Challacombe L; Touesnard N; Gagnon M; McDougall P; Strike C
Int J Drug Policy; 2023 Jan; 111():103905. PubMed ID: 36379109
[TBL] [Abstract][Full Text] [Related]
2. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.
Perri M; Kaminski N; Bonn M; Kolla G; Guta A; Bayoumi AM; Challacombe L; Gagnon M; Touesnard N; McDougall P; Strike C
Harm Reduct J; 2021 Aug; 18(1):85. PubMed ID: 34353323
[TBL] [Abstract][Full Text] [Related]
3. Women who use drugs: engagement in practices of harm reduction care.
Austin T; Lavalley J; Parusel S; Collins AB; Olding M; Boyd J
Harm Reduct J; 2023 Apr; 20(1):49. PubMed ID: 37055805
[TBL] [Abstract][Full Text] [Related]
4. Safer opioid supply: qualitative program evaluation.
Haines M; O'Byrne P
Harm Reduct J; 2023 Apr; 20(1):53. PubMed ID: 37081500
[TBL] [Abstract][Full Text] [Related]
5. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
[TBL] [Abstract][Full Text] [Related]
6. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
; Austin T; Boyd J
Harm Reduct J; 2021 Jan; 18(1):1. PubMed ID: 33407500
[TBL] [Abstract][Full Text] [Related]
7. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
[TBL] [Abstract][Full Text] [Related]
8. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia.
Pauly BB; Mamdani Z; Mesley L; McKenzie S; Cameron F; Edwards D; Howell A; Knott M; Scott T; Seguin R; Greer AM; Buxton JA
Int J Drug Policy; 2021 Feb; 88():103015. PubMed ID: 33176249
[TBL] [Abstract][Full Text] [Related]
9. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
10. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
[TBL] [Abstract][Full Text] [Related]
11. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
12. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
[TBL] [Abstract][Full Text] [Related]
13. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
Reed MK; Salcedo VJ; Guth A; Rising KL
J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
[TBL] [Abstract][Full Text] [Related]
14. Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study.
Marshall T; Viste D; Jones S; Kim J; Lee A; Jafri F; Krieg O; Ghosh SM
Harm Reduct J; 2023 Jun; 20(1):80. PubMed ID: 37355610
[TBL] [Abstract][Full Text] [Related]
15. New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.
Kurcevič E; Lines R
Harm Reduct J; 2020 Nov; 17(1):94. PubMed ID: 33256747
[TBL] [Abstract][Full Text] [Related]
16. Critical studies of harm reduction: Overdose response in uncertain political times.
Watson TM; Kolla G; van der Meulen E; Dodd Z
Int J Drug Policy; 2020 Feb; 76():102615. PubMed ID: 31837567
[TBL] [Abstract][Full Text] [Related]
17. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
[TBL] [Abstract][Full Text] [Related]
18. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
[TBL] [Abstract][Full Text] [Related]
19. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of U.S. harm reduction advocates on persuasive message strategies.
White SA; Lee R; Kennedy-Hendricks A; Sherman SG; McGinty EE
Harm Reduct J; 2023 Aug; 20(1):112. PubMed ID: 37596595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
